You just read:

NICE Recommends Erbitux® in Combination with Platinum-Based Chemotherapy for the Treatment of Recurrent and/or Metastatic Head and Neck Cancer in the Oral Cavity

News provided by

Merck

Aug 08, 2017, 05:57 ET